Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast

NCT05279924 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Prophylaxis with Emicizumab

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain